STOCK TITAN

Entera Bio: Venrock group reports 5.1% passive stake

The reported 5.1% position is attributed across three investment vehicles, with shared voting and dispositive power listed for the reporting group.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Entera Bio Ltd. (ENTX) is the issuer in a Schedule 13G reporting that a group beneficially owns 8,861,763 ordinary shares, or 5.1%, with shared voting and dispositive power. The reported position consists of 3,891,972 shares held by Venrock Healthcare Capital Partners III, L.P., 389,631 by VHCP Co-Investment Holdings III, LLC, and 4,580,160 by Venrock Healthcare Capital Partners EG, L.P. The percentage is based on 173,922,428 ordinary shares outstanding as of October 1, 2026. The reporting group also includes VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Y. Koh; Shah and Koh are voting members of the two management entities.

Beneficial ownership 8,861,763 ordinary shares Reported for each member of the reporting group
Ownership percentage 5.1% Percentage of the ordinary shares
Shares outstanding 173,922,428 ordinary shares As of October 1, 2026; basis for the reported ownership percentage
Venrock Healthcare Capital Partners III, L.P. holdings 3,891,972 ordinary shares Shares held by the investment vehicle
VHCP Co-Investment Holdings III, LLC holdings 389,631 ordinary shares Shares held by the investment vehicle
Venrock Healthcare Capital Partners EG, L.P. holdings 4,580,160 ordinary shares Shares held by the investment vehicle
beneficially owned financial
"aggregate number of ordinary shares of the Issuer beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power financial
"Shared Voting Power 8,861,763.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power financial
"Shared Dispositive Power 8,861,763.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ENTX shares did the reporting group beneficially own?

The reporting group reported beneficial ownership of 8,861,763 ordinary shares, equal to 5.1% of the class. The reported position consists of 3,891,972 shares held by Venrock Healthcare Capital Partners III, L.P., 389,631 by VHCP Co-Investment Holdings III, LLC, and 4,580,160 by Venrock Healthcare Capital Partners EG, L.P.

What share count was used as the basis for the ENTX ownership percentage?

The reported 5.1% ownership percentage is based on 173,922,428 ordinary shares outstanding as of October 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





M40527109

(CUSIP Number)
10/23/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Venrock Healthcare Capital Partners III, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:10/30/2026
VHCP Co-Investment Holdings III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Date:10/30/2026
Venrock Healthcare Capital Partners EG, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:10/30/2026
VHCP Management III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:10/30/2026
VHCP Management EG, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:10/30/2026
Nimish Shah
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:10/30/2026
Bong Y. Koh
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:10/30/2026
Exhibit Information

Exhibit 24.1 Power of Attorney for Bong Y. Koh Exhibit 24.2 Power of Attorney for Nimish P. Shah Exhibit 99.1 Joint Filing Agreement

Keep reading